Impens NR - Search Results

1

Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer.

Gijs M, Penner G, Blackler GB, Impens NR, Baatout S, Luxen A, Aerts AM. Gijs M, et al. Among authors: impens nr. Pharmaceuticals (Basel). 2016 May 19;9(2):29. doi: 10.3390/ph9020029. Pharmaceuticals (Basel). 2016. PMID: 27213406 Free PMC article.

2

Gallium-68-labelled NOTA-oligonucleotides: an optimized method for their preparation.

Gijs M, Dammicco S, Warnier C, Aerts A, Impens NR, D'Huyvetter M, Léonard M, Baatout S, Luxen A. Gijs M, et al. Among authors: impens nr. J Labelled Comp Radiopharm. 2016 Feb;59(2):63-71. doi: 10.1002/jlcr.3363. Epub 2015 Dec 29. J Labelled Comp Radiopharm. 2016. PMID: 26712111

3

Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.

D'Huyvetter M, Aerts A, Xavier C, Vaneycken I, Devoogdt N, Gijs M, Impens N, Baatout S, Ponsard B, Muyldermans S, Caveliers V, Lahoutte T. D'Huyvetter M, et al. Contrast Media Mol Imaging. 2012 Mar-Apr;7(2):254-64. doi: 10.1002/cmmi.491. Contrast Media Mol Imaging. 2012. PMID: 22434639 Free article.

4

Aptamers as radiopharmaceuticals for nuclear imaging and therapy.

Gijs M, Aerts A, Impens N, Baatout S, Luxen A. Gijs M, et al. Nucl Med Biol. 2016 Apr;43(4):253-71. doi: 10.1016/j.nucmedbio.2015.09.005. Epub 2015 Sep 28. Nucl Med Biol. 2016. PMID: 26746572 Review.

5

Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy.

Aerts A, Impens NR, Gijs M, D'Huyvetter M, Vanmarcke H, Ponsard B, Lahoutte T, Luxen A, Baatout S. Aerts A, et al. Among authors: impens nr. Curr Pharm Des. 2014;20(32):5218-44. doi: 10.2174/1381612819666140110114902. Curr Pharm Des. 2014. PMID: 24606796 Review.

6

Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody.

D'Huyvetter M, Vincke C, Xavier C, Aerts A, Impens N, Baatout S, De Raeve H, Muyldermans S, Caveliers V, Devoogdt N, Lahoutte T. D'Huyvetter M, et al. Theranostics. 2014 Apr 25;4(7):708-20. doi: 10.7150/thno.8156. eCollection 2014. Theranostics. 2014. PMID: 24883121 Free PMC article.

7

Joint research towards a better radiation protection-highlights of the Fifth MELODI Workshop.

Aerts AM, Impens NR, Baatout S, Benotmane MA, Camps J, Dabin JM, Derradji H, Grosche B, Horemans N, Jourdain JR, Moreels M, Perko T, Quintens R, Repussard J, Rühm W, Schneider T, Struelens L, Hardeman F. Aerts AM, et al. Among authors: impens nr. J Radiol Prot. 2014 Dec;34(4):931-56. doi: 10.1088/0952-4746/34/4/931. Epub 2014 Nov 28. J Radiol Prot. 2014. PMID: 25431966

8

The joint roadmap for radiation protection research: outreach and future.

Impens NREN, Salomaa S. Impens NREN, et al. J Radiol Prot. 2021 Sep 27;41(4). doi: 10.1088/1361-6498/ac1c96. J Radiol Prot. 2021. PMID: 34380130

9

When a duck is not a duck; a new interdisciplinary synthesis for environmental radiation protection.

Mothersill C, Abend M, Bréchignac F, Iliakis G, Impens N, Kadhim M, Møller AP, Oughton D, Powathil G, Saenen E, Seymour C, Sutcliffe J, Tang FR, Schofield PN. Mothersill C, et al. Environ Res. 2018 Apr;162:318-324. doi: 10.1016/j.envres.2018.01.022. Epub 2018 Feb 4. Environ Res. 2018. PMID: 29407763 Free article.

10

Ionizing radiation-induced circulatory and metabolic diseases.

Tapio S, Little MP, Kaiser JC, Impens N, Hamada N, Georgakilas AG, Simar D, Salomaa S. Tapio S, et al. Environ Int. 2021 Jan;146:106235. doi: 10.1016/j.envint.2020.106235. Epub 2020 Nov 3. Environ Int. 2021. PMID: 33157375 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters